# Clovis Oncology, Inc.: Form D filings

Clovis Oncology, Inc., a pharmaceuticals company in Boulder, CO, filed 5 Form D notices with the SEC between 2009 and 2013. The latest, on November 27, 2013, reports $192 million sold of an offering with no set size to 9 investors.

Find out what Clovis Oncology, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Clovis%20Oncology%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Clovis%20Oncology%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fclovis-oncology-inc-1466301)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Clovis%20Oncology%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Clovis%20Oncology%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fclovis-oncology-inc-1466301)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Colorado](https://specstream.ai/data/form-d/state/colorado): 1,787 rows, by operating companies, filed since November 1, 2024, $89.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/colorado
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2525 28TH STREET, SUITE 100, Boulder, CO, 80301
- Phone: (303) 625-5000
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2009
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1466301

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 27, 2013 | New notice | Indefinite | $191,962,756 | Indefinite | 9 | Nov 19, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1466301/000146630113000001/0001466301-13-000001-index.htm) |
| Jun 2, 2011 | New notice | Indefinite | $20,000,000 | Indefinite | 18 | May 25, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1466301/000152194611000007/0001521946-11-000007-index.htm) |
| May 18, 2011 | Amendment | $146,300,000 | $146,300,000 | $0 | 19 | May 15, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1466301/000152077311000001/0001520773-11-000001-index.htm) |
| May 19, 2010 | New notice | $146,300,000 | $146,300,000 | $0 | 19 | May 15, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1466301/000146630110000001/0001466301-10-000001-index.htm) |
| Jun 25, 2009 | New notice | $146,300,000 | $146,300,000 | $0 | 19 | May 15, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1466301/000146630109000001/0001466301-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Gillian C. Ivers-Read | Executive Officer |  |
| Paul C. Klingenstein | Director |  |
| James C. Blair | Director |  |
| Steven L. Hoerter | Executive Officer |  |
| Brian G. Atwood | Director |  |
| M. James Barret | Director |  |
| Keith L. Flaherty | Director |  |
| Patrick J. Mahaffy | Executive Officer, Director |  |
| Erle T. Mast | Executive Officer |  |
| Thorlef J. Spickschen | Director |  |
| Ginger L. Graham | Director |  |
| Andrew R. Allen | Executive Officer |  |
| Edward J. McKinley | Director |  |

[Every Form D from the week of Nov 25, 2013](https://specstream.ai/data/form-d/week/2013-11-25) · [All recent filings in Colorado](https://specstream.ai/data/form-d/state/colorado) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Clovis Oncology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).